Literature DB >> 15580242

Cancer vaccines: pessimism in check.

Simone Mocellin, Susanna Mandruzzato, Vincenzo Bronte, Francesco M Marincola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15580242     DOI： 10.1038/nm1204-1278

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.

Authors:  Sourabh Ghosh; Rachel Rosenthal; Paul Zajac; Walter P Weber; Daniel Oertli; Michael Heberer; Ivan Martin; Giulio C Spagnoli; Anca Reschner
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 2.  Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review.

Authors:  Benqiang Rao; Minyan Han; Lei Wang; Xiaoyan Gao; Jun Huang; Meijin Huang; Huanliang Liu; Jianping Wang
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

3.  Current clinical trials for melanoma vaccines: where do we stand?

Authors:  Adam I Riker; Erika Bisgaard
Journal:  Melanoma Manag       Date:  2016-11-30

4.  Analysis of vaccine-induced T cells in humans with cancer.

Authors:  Stefanie L Slezak; Andrea Worschech; Ena Wang; David F Stroncek; Francesco M Marincola
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Melanoma controversies: clinical significance of nodal micrometastases and the future of melanoma vaccines.

Authors:  Kelly M McMasters
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

Review 6.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

7.  A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients.

Authors:  Daniel R Ciocca; Patrick Frayssinet; F Darío Cuello-Carrión
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

Review 8.  EGFRvIII-targeted vaccination therapy of malignant glioma.

Authors:  Bryan D Choi; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Roger E McLendon; Darell D Bigner; John H Sampson
Journal:  Brain Pathol       Date:  2009-10       Impact factor: 6.508

Review 9.  Anaplastic lymphoma kinase: an oncogene for tumor vaccination.

Authors:  Cristina Mastini; Cinzia Martinengo; Giorgio Inghirami; Roberto Chiarle
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

Review 10.  Progress and challenges in the vaccine-based treatment of head and neck cancers.

Authors:  Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.